GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 173   

Articles published

GSK 46.64 -0.68 (-1.44%)
price chart
Ebola Aid Being Flown To Affected Areas
Previous donations were made by corporations like Johnson & Johnson (JNJ), GlaxoSmithKline plc (ADR) (GSK), Merck & Co.
GSK China Fined $490 Million For Bribery
GlaxoSmithKline plc's (ADR) (GSK) Chinese subsidiary, GSK China Investment Co. Ltd., has been found guilty by Chinese Courts of bribing doctors to increase sales of its Consumer Health business.
GlaxoSmithKline plc (ADR) (GSK) Faces Fines Worth $489 Million, Former Head ...  StockWise Daily
GlaxoSmithKline plc (ADR) (NYSE:GSK) Earns $500 Million Slap In China  WallStreetPR
Related articles »  
UK Regulator Recommends GSK's Skin Cancer Drug
GlaxoSmithKline plc (ADR) (GSK) has secured the support of the National Institute for Health and Care Excellence (NICE).
Related articles »  
GSK On Track To Develop Safe And Tested Ebola Vaccine
GlaxoSmithKline plc (ADR) (GSK) is on track to develop its Ebola virus vaccine, which may help control the epidemic that has killed thousands in West Africa.
Related articles »  
GSK Facing Multimillion Dollar Settlement Or Fines Because Of US Probe
GlaxoSmithKline plc (ADR) (GSK) is back once again in the negative spotlight as details have emerged that a US anti-bribery probe touched upon the firm's Chinese consumer healthcare business in 2012, for possible violations of anti-bribery laws.
Related articles »  
GlaxoSmithKline plc (ADR) (GSK) Nearing on Ebola Eradication
GlaxoSmithKline plc (ADR) (NYSE:GSK) remains committed to eradicating the deadly virus which has already claimed more than 2,000 lives in Western Africa and is considered as the worst occurrence of such an epidemic in the region.
GlaxoSmithKline plc (ADR) (GSK) Might Face Legal Trouble in Chinese ...  StockWise Daily
GlaxoSmithKline plc's "Hold" Rating Reaffirmed at Deutsche ...  WKRB News
Related articles »  
Novartis Wins The Battle Over Bronchodilators Against GSK
Novartis AG ADR (NVS) reported yesterday that its once-daily Ultibro (Breezhaler) bronchodilator outperformed GlaxoSmithKline plc's (ADR) (GSK) twice-daily blockbuster Seretide (Accuhaler) bronchodilator in Phase-III trials. The results of the Phase ...
Related articles »  
Ban Ki-moon Calls For $1 Billion To Control Ebola Outbreak
The World Health Organization's (WHO) Director General Margaret Chan, in her address to the meeting, said that Ebola has developed from a health crisis to a humanitarian and an economic crisis.
Related articles »  
GSK Will Not Be Able To Complete Its Flu Vaccine Order For Canada
GlaxoSmithKline plc (ADR) (GSK), Canada's largest flu vaccine supplier, announced on September 4 that it will not be able to fulfill 30% of its promised flu vaccine order for the 2014-15 flu season.
Related articles »  
SEC Gives 30 Million Reasons For Blowing The Whistle
The Securities and Exchange Commission (SEC) revealed yesterday that it will award more than $30 million to an anonymous foreign tipster, which is the largest prize in the SEC's history and is more than twice the size of the previous highest payout ...
Related articles »